Gestational diabetes is on the rise among pregnant people, and now Ohio State University Wexner Medical Center has received a $12 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to define the best treatment. The study will compare oral metformin versus injectable insulin.